ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 301

Predictive Factors for Response to Ultrasound-Guided Intra-Articular Glucocorticoids in Knee Osteoarthritis

Samy Slimani1, Amel Aissoug2, Souhila Aouidane3, Hocine Bounecer1, Hachemi Makhloufi1 and Aïcha Ladjouz Rezig4, 1Department of Medicine, University of Batna, Batna, Algeria, 2Private practice office of rheumatology, Batna, Algeria, 3Public Health, University Hospital of Batna, Batna, Algeria, 4Department of Medicine, University of Algiers 1, Algiers, Algeria

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Knee, osteoarthritis and ultrasound

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 13, 2016

Title: Osteoarthritis – Clinical Aspects - Poster I

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: To investigate predictive factors for good outcome of ultrasound intra-articular glucocorticoids in knee osteoarthritis (OA).

Methods: We conducted a prospective monocenter cohort study including 116 patients with knee OA, after failure to standard treatments, with pain > 4 (numerical rating scale NRS 0-10). Patients received an ultrasound-guided injection of 40 mg triamcinolone acetonide in their most painful knee. We exhaustively collected demographic and clinical data at inclusion, as well as lab, radiographs and ultrasound parameters of the included knees. WOMAC score was calculated at inclusion and after 4 weeks. Responders were defined as patients with at least 40% improvement of their WOMAC score. Univariate analysis was performed in order to select possible predictive factors, and stepwise multiple logistic regression analyses were conducted to identify predictors of response.

Results: Among the 116 patients, 101 were females. Median age was 64 years (40-85) and mean duration of the disease was 14.1 ± 14,8 years. Mean BMI was 29.9 ± 3.8 Kg/m2. Mean NRS of pain was 8.4 ± 1.2 and mean WOMAC was 73.3 ± 11,8 at inclusion. 70.0% of the knees were grade 3 or 4 of Kellgren-Lawrence. 98% of knees expressed ultrasound synovial effusion and/or hypertrophy at inclusion. After 4 weeks, 61.2% of patients were responders. Regression analysis showed that patients with a BMI < 30 Kg/m2(OR=0.38, 95%CI 0.16-0.89) and an ESR < 20 mm (OR=0.27, 95%CI 0.08-0.90) were more likely to respond to ultrasound-guided glucocorticoids injection. Having both predictive factors of good response increases the response rate to 73.5%, whereas having no predictive factor decreases the response rate to 25.0%.

Conclusion: Our study is the largest study evaluating predictive factors of response for intra-articular glucocorticoids injections in knee OA. Also, it is the first study of predictive factors for ultrasound-guided injections. Patients with high BMIs and high ESR seem less likely to respond to intra-articular injections.


Disclosure: S. Slimani, None; A. Aissoug, None; S. Aouidane, None; H. Bounecer, None; H. Makhloufi, None; A. Ladjouz Rezig, None.

To cite this abstract in AMA style:

Slimani S, Aissoug A, Aouidane S, Bounecer H, Makhloufi H, Ladjouz Rezig A. Predictive Factors for Response to Ultrasound-Guided Intra-Articular Glucocorticoids in Knee Osteoarthritis [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/predictive-factors-for-response-to-ultrasound-guided-intra-articular-glucocorticoids-in-knee-osteoarthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/predictive-factors-for-response-to-ultrasound-guided-intra-articular-glucocorticoids-in-knee-osteoarthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology